Effect of antiseptics on the antibiofilm activity of innate immune peptides
Russian Journal of Immunology · 31.10.2026 · 29 (3) · 509-514
DOI: 10.46235/1028-7221-17465-eoa ↗Kurz gefasst
Fachartikel in der Zeitschrift Russian Journal of Immunology, online erschienen am 31.10.2026. Verfasst von E. V. Vladimirova. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Bacterial biofilms develop in 65% of nosocomial infections, including wound lesions, where they promote resistance to antibiotics and immune defenses, thus complicating treatment. The ESKAPEE group of bacterial pathogens (Enterococcus spp., Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Escherichia coli, Enterobacter spp.) is especially challenging. Antimicrobial peptides of innate immunity are considered as promising agents for the treatment of wound infections caused by such microorganisms, since they possess multiple antibacterial mechanisms, including antibiofilm activity and a lower probability of resistance development. Meanwhile, antiseptic compounds are widely used in management of wound infections as standard tools for the wound surface treatment, thus determining the importance of testing their compatibility with antimicrobial agents to prevent antagonism and maximize the effect of combination therapy. The aim of this study was to evaluate the effect of antiseptics on the antibiofilm activity of synthetic analogs of innate immune peptides. The antiseptics chlorhexidine, prontosan, and betadine, as well as chemically synthesized analogs of innate immune peptides: protegrin-1, micecilin, bactenecin 3.4, and its structural modification (RFR-ChBac3.4(1-14), were used in the study. The numbers of emerging biofilms were determined spectrophotometrically by Crystal Violet staining. It was found that protegrin-1 exhibits antibiofilm activity at the concentration range of 2-4 μM; micecilin, at 4-16 μM; bactenecin 3.4, at 2-8 μM; modified bactenecin 3.4 (RFR-ChBac3.4 (1-14), at 16 μM; chlorhexidine, at 16-32 μg/mL; prontosan, at 4-16 μg/mL, and betadine, at 1562-6248 μg/mL, as tested with P. aeruginosa MDR 522/17 and A. baumannii 7226/16. It was also shown that the use of peptides in combination with antiseptics may enhance their antibiofilm effects against P. aeruginosa and A. baumannii biofilms. Synergistic and additive effects against these bacteria were identified for the following combinations: protegrin-1 or micecilin with chlorhexidine, bactenecin 3.4 with chlorhexidine and prontosan, and RFR-ChBac3.4 (1- 14) with chlorhexidine, prontosan, and betadine. Hence, these joint effects represent a promising basis for combined therapy of wound infections.
Zitieren
APA
Vladimirova, E. V. (2026). Effect of antiseptics on the antibiofilm activity of innate immune peptides. Russian Journal of Immunology, 29(3), 509-514. https://doi.org/10.46235/1028-7221-17465-eoa
Vancouver
Vladimirova EV. Effect of antiseptics on the antibiofilm activity of innate immune peptides. Russian Journal of Immunology. 2026;29(3):509-514. doi:10.46235/1028-7221-17465-eoa
BibTeX
@article{Vladimirova2026,
author = {Vladimirova, E. V.},
title = {Effect of antiseptics on the antibiofilm activity of innate immune peptides},
journal = {Russian Journal of Immunology},
year = {2026},
volume = {29},
number = {3},
pages = {509--514},
doi = {10.46235/1028-7221-17465-eoa}
}
EUVIMED